Published date: 9 September 2021

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 2 June 2021, 1pm

Contract summary

Industry

  • Influenza vaccines - 33651660

Location of contract

Channel Islands, England, Isle of Man

Value of contract

£17,046,105

Procurement reference

CF-0340900D0O000000rwimUAA1

Published date

9 September 2021

Closing date

2 June 2021

Closing time

1pm

Contract start date

1 September 2021

Contract end date

31 August 2022

Contract type

Supply contract

Procedure type

Open procedure (above threshold)

Any interested supplier may submit a tender in response to an opportunity notice.

This procedure can be used for procurements above the relevant contract value threshold.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

No

Description

NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months

More information

Links

Award information

Awarded date

18 August 2021

Contract start date

1 September 2021

Contract end date

31 August 2022

Total value of contract

£17,046,105

This contract was awarded to 2 suppliers.

Aventis Pharma ltd t/a Sanofi

Address

410 Thames Valley, Park Drive, Reading, Reading, RG6 1PT

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Seqirus UK Limited

Address

Point, 29 Market Street, Maidenhead, SL6 8AA

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Contact name

Philip Grieve

Address

2nd Floor, Rutland House
Runcorn
WA7 2ES
GB

Email

philip.grieve@nhs.net